68999-706-24 : NDC 2026 Code

68999-706-24 : Lamivudine Oral ( Lamivudine )

Additionally :

You can get information about “68999-706-24” NDC code in 68999-706-24 in HTML format

HTML | 68999-706-24 in TXT (Plain Text) format

TXT | 68999-706-24 in PDF (Portable Document Format)

PDF | 68999-706-24 in XML format

XML formats.

NDC Code : 68999-706-24 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "68999-706-24",
    "PackageDescription": "2 TRAY in 1 BOX (68999-706-24)  / 10 CUP in 1 TRAY / 30 mL in 1 CUP (68999-706-30) ",
    "NDC11Code": "68999-0706-24",
    "ProductNDC": "68999-706",
    "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
    "ProprietaryName": "Lamivudine",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Lamivudine Oral",
    "DosageFormName": "SOLUTION",
    "RouteName": "ORAL",
    "StartMarketingDate": "20141031",
    "EndMarketingDate": null,
    "MarketingCategoryName": "ANDA",
    "ApplicationNumber": "ANDA203564",
    "LabelerName": "Chartwell Govermental &amp; Specialty RX, LLC.",
    "SubstanceName": "LAMIVUDINE",
    "StrengthNumber": "10",
    "StrengthUnit": "mg/mL",
    "Pharm_Classes": "Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA]",
    "DEASchedule": null,
    "Status": "Active",
    "LastUpdate": "2026-01-05",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20271231",
    "StartMarketingDatePackage": "20251224",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}